Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near San Francisco, CA

96 studies for Lung Cancer are recruiting at 299 sites within 50 miles of San Francisco, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near San Francisco.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near San Francisco

Showing the 50 nearest of 96 studies.
  1. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Kaiser Permanente-San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    40 sites within 50 mi
  2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Kaiser Permanente-San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    24 sites within 50 mi
  3. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-San Francisco (San Francisco, CA); Kaiser Permanente-South San Francisco (South San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  4. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-San Francisco (San Francisco, CA); Kaiser Permanente-South San Francisco (South San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  5. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Kaiser Permanente-San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  6. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-San Francisco (San Francisco, CA); Kaiser Permanente-South San Francisco (South San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  7. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-San Francisco (San Francisco, CA); Veterans Affairs Medical Center - San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  8. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Kaiser Permanente-San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  9. Distance-Based Exercise to Preserve Function and Prevent Disability

    NCT07059884

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-San Francisco (San Francisco, CA); Kaiser Permanente-Oakland (Oakland, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  10. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Mills-Peninsula Medical Center (Burlingame, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  11. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center-Pacific Campus (San Francisco, CA); Alta Bates Summit Medical Center-Herrick Campus (Berkeley, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  12. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCSF Zuckerberg San Francisco General Hospital (San Francisco, CA); Marin Cancer Center (Greenbrae, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  13. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

    NCT05297734

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Foundation Research Institute (San Francisco, CA); University of San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  14. Biomarkers for Risk Stratification in Lung Cancer

    NCT03774758

    • Observational
    • Ages 40 years and older
    • Sex: All

    Nearest sites: San Francisco VA Medical Center (San Francisco, CA); University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: San Francisco Veterans Affairs Medical Center (San Francisco, CA); UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

    NCT06627647

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (San Francisco, CA); Research Site (Walnut Creek, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: California Pacific Medical Center (San Francisco, CA); Marin Cancer Care Inc (Greenbrae, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  18. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (San Francisco, CA); Massive Bio SYNERGY-AI site (Stanford, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    NCT06162221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCSF Medical Center - Mission Bay (San Francisco, CA); Stanford University - Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

    NCT06692738

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (San Francisco, CA); Research Site (Walnut Creek, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

    NCT07185997

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCSF Medical Center-Mission Bay (San Francisco, CA); Kaiser Permanente Medical Center (Vallejo, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. A Multicenter Cancer Biospecimen Collection Study

    NCT04510129

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Curebase (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Medical Center at Mission Bay (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

    NCT04665206

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

    NCT04913285

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    NCT05786924

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (UCSF) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

    NCT05882058

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    NCT06203210

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Mission Bay Mission Hall (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

    NCT06244771

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    NCT06281678

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California, San Francisco (UCSF) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

    NCT06312137

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: San Francisco Oncology Associates ( Site 0066) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

    NCT06326411

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    NCT06343402

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Smoking Cessation CM for Veterans With or at Risk for Cancer

    NCT06432985

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: San Francisco VA Medical Center, San Francisco, CA (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

    NCT06452277

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Bakar Precision Cancer Medicine Building - Thoracic Surgery and Oncology (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Medical Center at Mission Bay ( Site 0178) (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of MGC028 in Participants With Advanced Solid Tumors

    NCT06723236

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF - Helen Diller Family Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

    NCT06810544

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California at San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    NCT06917079

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Evaluating the Impact of CONNECT in a Multilingual Population

    NCT07111936

    • Interventional
    • Ages 50 to 80 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    NCT07145255

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of ZW251 in Participants With Advanced Solid Tumors

    NCT07164313

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

    NCT07195695

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of California San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

    NCT07491497

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

    NCT07566052

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCSF Health - UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

    NCT07473128

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Pharmacosmos Investigational Site (Oakland, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Alameda, CA); Clinical Study Site (Sunnyvale, CA)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    NCT07144280

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Alta Bates Summit Medical Center Comprehensive Cancer Center (Berkeley, CA); John Muir Health Cancer Center (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    5 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.